United Capital Financial Advisers LLC bought a new stake in VanEck Rare Earth/Strategic Metals ETF (NYSEARCA:REMX – Get Rating) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,087 shares of the company’s stock, valued at approximately $257,000.
Other hedge funds have also made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its stake in shares of VanEck Rare Earth/Strategic Metals ETF by 2,692.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 363 shares of the company’s stock valued at $31,000 after acquiring an additional 350 shares during the period. SeaCrest Wealth Management LLC acquired a new stake in VanEck Rare Earth/Strategic Metals ETF during the 2nd quarter valued at $34,000. Parkside Financial Bank & Trust acquired a new stake in VanEck Rare Earth/Strategic Metals ETF during the 3rd quarter valued at $33,000. Worth Asset Management LLC acquired a new stake in VanEck Rare Earth/Strategic Metals ETF during the 1st quarter valued at $37,000. Finally, Steward Partners Investment Advisory LLC grew its holdings in VanEck Rare Earth/Strategic Metals ETF by 437.0% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 639 shares of the company’s stock valued at $55,000 after purchasing an additional 520 shares in the last quarter.
VanEck Rare Earth/Strategic Metals ETF Stock Down 3.9 %
REMX opened at $81.98 on Wednesday. The company has a fifty day simple moving average of $87.10 and a 200 day simple moving average of $89.04. VanEck Rare Earth/Strategic Metals ETF has a twelve month low of $74.36 and a twelve month high of $127.50.
Read More
- Get a free copy of the StockNews.com research report on VanEck Rare Earth/Strategic Metals ETF (REMX)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets “Powelled”: S&P 500 Confirms Resistance
- Rivian Plummets, But Is This 2023’s Greatest Buying Opportunity?
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Receive News & Ratings for VanEck Rare Earth/Strategic Metals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Rare Earth/Strategic Metals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
